ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
Access to Document
Other files and links
Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild to moderate coronavirus disease 2019 (COVID-19). / Heald-Sargent, Taylor; Muller, William J.; Zheng, Xiaotian et al.In: JAMA Pediatrics, Vol. 174, No. 9, 01.09.2020, p. 902-903.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - Age-related differences in nasopharyngeal severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) levels in patients with mild to moderate coronavirus disease 2019 (COVID-19)
AU - Heald-Sargent, Taylor
AU - Muller, William J.
AU - Zheng, Xiaotian
AU - Rippe, Jason
AU - Patel, Ami B.
AU - Kociolek, Larry K.
N1 - Funding Information: Funding/Support: Drs Heald-Sargent and Kociolek were supported by grants T32AI095207 and K23AI123525, respectively, from the National Institute of Allergy and Infectious Diseases. Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication. 1. Lu X, Zhang L, Du H, et al; Chinese Pediatric Novel Coronavirus Study Team. SARS-CoV-2 infection in children. N Engl J Med. 2020;382(17):1663-1665. doi:10.1056/NEJMc2005073 2. Paules C, Subbarao K. Influenza. Lancet. 2017;390(10095):697-708. doi:10.1016/S0140-6736(17)30129-0 3. Cao Q, Chen YC, Chen CL, Chiu CH. SARS-CoV-2 infection in children: transmission dynamics and clinical characteristics. J Formos Med Assoc.2020; 119(3):670-673. doi:10.1016/j.jfma.2020.02.009 4. Liu Y, Yan LM, Wan L, et al. Viral dynamics in mild and severe cases of COVID-19. Lancet Infect Dis. 2020;20(6):656-657. doi:10.1016/S1473-3099(20) 30232-2 5. L’Huillier AG, Torriani G, Pigny F, Kaiser L, Eckerle I. Culture-competent SARS-CoV-2 in nasopharynx of symptomatic neonates, children, and adolescents. Emerg Infect Dis. 2020;26(10):26. Funding Information: Funding/Support: Data collection and manuscript preparation were supported by research grant R01DA001411 (Drs Miech and Johnston) and development of the manuscript was supported by research grant R01DA037902 (Dr Patrick) from the National Institute on Drug Abuse. Funding Information: BioPharma, Astellas Pharma, AstraZeneca, Abbott Laboratories, Janssen Pharmaceuticals, Karius, Merck, Melinta Therapeutics, Roche, Tetraphase Pharmaceuticals, and Seqirus. Dr Patel has received grants from Aqua Pharmaceuticals. Dr Kociolek has received grants from Merck. No other disclosures were reported.
PY - 2020/9/1
Y1 - 2020/9/1
UR - http://www.scopus.com/inward/record.url?scp=85089137962&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85089137962&partnerID=8YFLogxK
U2 - 10.1001/jamapediatrics.2020.3651
DO - 10.1001/jamapediatrics.2020.3651
M3 - Letter
C2 - 32745201
AN - SCOPUS:85089137962
VL - 174
SP - 902
EP - 903
JO - A.M.A. American journal of diseases of children
JF - A.M.A. American journal of diseases of children
SN - 2168-6203
IS - 9